Adult T-cell leukemia/lymphoma triggered by adalimumab

dc.creatorBittencourt, Achilea Candida Lisboa
dc.creatorOliveira, Pedro D.
dc.creatorBittencourt, Valéria Gusmão
dc.creatorCarvalho Filho, Edgar Marcelino de
dc.creatorFarré, Lourdes
dc.creatorBittencourt, Achilea Candida Lisboa
dc.creatorOliveira, Pedro D.
dc.creatorBittencourt, Valéria Gusmão
dc.creatorCarvalho Filho, Edgar Marcelino de
dc.creatorFarré, Lourdes
dc.date.accessioned2022-10-07T19:23:22Z
dc.date.available2022-10-07T19:23:22Z
dc.date.issued2013
dc.identifier1386-6532
dc.identifierhttp://repositorio.ufba.br/ri/handle/ri/15547
dc.identifierv. 58, n. 2
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4013516
dc.description.abstractHere, we describe a 48-year-old woman infected by the human T-cell lymphotropic virus type 1 (HTLV-1) with spondyloarthritis, uveitis, bilateral episcleritis and neurogenic bladder. She had a history of a probable infective dermatitis associated with HTLV-1 (IDH) in childhood. After the use of adalimumab, she developed lymphocytosis and a cutaneous lymphoma associated with IDH. She had the diagnoses of IDH and of chronic adult T-cell leukemia/lymphoma, supported by the demonstration of proviral integration in the cutaneous lesion.
dc.languageen
dc.rightsAcesso Aberto
dc.sourcehttp://dx.doi.org/10.1016/j.jcv.2013.07.011
dc.subjectAdult T-cell leukemia/lymphoma
dc.subjectInfective dermatitis associated with HTLV-1
dc.subjectAdalimumab
dc.subjectAnti-TNF-α drugs
dc.titleAdult T-cell leukemia/lymphoma triggered by adalimumab
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución